Trials / Conditions / Pancreatic Neuroendocrine Tumors (pNET)

Pancreatic Neuroendocrine Tumors (pNET)

4 registered clinical trials studyying Pancreatic Neuroendocrine Tumors (pNET) — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendoc NCT07536087	Institute for Clinical and Experimental Medicine	N/A
Not Yet Recruiting	Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2 NCT07274657	GCS Ramsay Santé pour l'Enseignement et la Recherche	N/A
Completed	BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR NCT01658436	Novartis Pharmaceuticals	Phase 2
Terminated	Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumor NCT01628913	Novartis Pharmaceuticals	Phase 2